Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHP615 in pediatric status epilepticus
NCT03336645Phase 3Completed
- Sponsor
- Takeda
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Countries
- 1
01
Overview
A Phase 3 trial of midazolam in status epilepticus (SE), sponsored by Takeda. Started Oct 2017; status: completed.
02
Drugs
midazolam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT03336645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03336645.